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ABSTRACT
We have developed a new bioinformatics approach
called ECMFinder (Evolutionary Conserved Motif
Finder). This program searches for a given DNA
motif within the entire genome of one species and
uses the gene association information of a potential
transcription factor-binding site (TFBS) to screen
the homologous regions of a second and third spe-
cies. If multiple species have this potential TFBS in
homologous positions, this program recognizes the
identified TFBS as an evolutionary conserved motif
(ECM). This program outputs a list of ECMs, which
can be uploaded as a Custom Track in the UCSC
genome browser and can be visualized along with
other available data. The feasibility of this approach
was tested by searching the genomes of three
mammals (human, mouse and cow) with the DNA-
binding motifs of YY1 and CTCF. This program
successfully identified many clustered YY1- and
CTCF-binding sites that are conserved among
these species but were previously undetected. In
particular, this program identified CTCF-binding
sites that are located close to the Dlk1, Magel2
and Cdkn1c imprinted genes. Individual ChIP experi-
ments confirmed the in vivo binding of the YY1 and
CTCF proteins to most of these newly discovered
binding sites, demonstrating the feasibility and
usefulness of ECMFinder.
INTRODUCTION
Identifying transcription factor-binding sites (TFBSs)
within the raw genome sequences of higher eukaryotes is
quite challenging using current knowledge and methods.
The sequences and sizes of many known TFBSs are
usually degenerate and very short (<15bp in length) com-
pared to the large sizes of the genomes. (100Mb to several
Gigabases) (1–4). Thus, the huge number of fortuitous
false-positive TFBSs easily outnumber the functionally
relevant TFBSs (5). To ﬁlter out this vast majority
of false positives, several bioinformatics strategies focus
on small fractions of genomes which have been preﬁltered
based on their evolutionary conservation (6–10). These
evolutionary conserved regions (ECRs), which are deﬁned
as sequences at least 100bp long with at least 70% iden-
tity, include most of the protein-coding exons as well as
promoters, enhancers and repressors (11). Targeting these
ECRs could be a logical, ﬁrst step for ﬁnding TFBSs.
However, recent large-scale genomic studies with chroma-
tin immunoprecipitation (ChIP)-based ChIP-chip or
ChIP-seq techniques indicate that many in vivo TFBSs
are also found in genomic regions that are not evolutio-
narily conserved (12,13). Similarly, according to studies
from the genomic imprinting ﬁeld, the most critical
regions for controlling imprinting, imprinting control
regions (ICRs), exhibit no sequence conservation among
diﬀerent species. Instead, they tend to display high levels
of sequence divergence, but harbor unusual tandem arrays
of a single type of TFBSs, such as YY1- and CTCF-
binding sites (14,15). These recent ﬁndings emphasize a
need to implement diﬀerent approaches to identify TFBSs.
As part of the eﬀort of analyzing mammalian imprinted
domains, we have developed a bioinformatics approach
called Evolutionary Conserved Motif Finder
(ECMFinder). ECMFinder searches through the genome
of one species using a given DNA motif, and catalogs the
gene association information of this potential TFBS, which
is subsequently used for screening the homologous gene
regions of the second and third species. If all compared
species have the potential TFBS in homologous positions,
this program recognizes the identiﬁed TFBS as an evolu-
tionary conserved motif (ECM). In contrast to existing
approaches, this new approach does not limit searchable
regions from a given genome based on their evolutionary
conservation levels. Instead, this program utilizes the
positional information of a potential TFBS relative to its
nearbygeneandtheconservationofitsassociationwiththe
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feasibility of this new approach, we searched through the
genomes of three mammals (human, mouse and cow) with
the consensus DNA-binding motifs of YY1 and CTCF.
ECMFinder successfully identiﬁed 31 YY1 candidate
downstream genes which had YY1-binding sites near
their promoter regions. In addition, this program also iso-
lated 174 loci, each of which has more than three CTCF-
binding sites. The in vivo binding to the YY1 and CTCF
proteins of some of these newly discovered binding sites
was further conﬁrmed using ChIP experiments.
MATERIALS AND METHODS
Data sourcesand implementation
Human (hg18), mouse (mm9), cow (bosTau4) and chicken
(galGal3) genome sequences were obtained from the
UCSC Genome Bioinformatics site (data set by chromo-
some, ftp://hgdownload.cse.ucsc.edu). Annotated table
data for all genes were collected using the Table Browser
(group: Genes and Gene Prediction Tracks, track: RefSeq
Genes, region: genome). Annotations of homologs were
obtained from the HomoloGene database (ftp://ftp.ncbi.
nih.gov/pub/HomoloGene/build62). The true binding site
of E2F1 used in Table 1 was obtained from mouse embry-
onic stem cell ChIP-seq data (16) and converted to the
mm9 version (NCBI Build 37) with the liftOver tool
(http://genome.ucsc.edu/cgi-bin/hgLiftOver). The mouse
and human CTCF ChIP-seq data used in Table 2 were
obtained from the study of mouse ES cells (16) and
human CD4
+ T cells (http://dir.nhlbi.nih.gov/papers/
lmi/epigenomes/hgTcell.html) (17). The human CTCF
ChIP-chip data used in Figure 4 were obtained and con-
verted to the hg18 version by using the liftOver tool (13).
ECMFinder and its source code can be downloaded
freely at the following website: http://jookimlab.lsu.edu/
?q=node/73. Before using this tool, the genome sequences
listed above must be downloaded (see ‘readme.txt’ for
details).
Common gene annotation table (CGAT) database
We used the HomoloGene database (release 62) to deﬁne
homologous regions among species. Coordinates and
other information about homologous genes were extracted
from the RefSeq database and merged with the
HomoloGene database using Galaxy (http://galaxy.
psu.edu/). We generated the CGAT database with this
merged ﬁle, ‘X.cgat’ (X denotes species’ name), which con-
tains all the information about homologous genes from
‘X’ species. ECMFinder uses the transcription start sites
(TSSs) of genes to deﬁne their homologous regions. Thus,
in the case of some genes with multiple TSSs, ECMFinder
selects one of these TSSs. Using this approach, 15 CGAT
ﬁles were constructed with diﬀerent combinations of the
four species (human, mouse, cow and chicken). As the
number of species was increased, the size of the CGAT













TFBS-conserved PWM Human–mouse–rat alignment 2.13
f 12.91 0.06 0.35
Single motif ECMFinder Regex
e TSS+/–2kb M 61.37 11.09 1.79 0.32
MH 59.31 11.80 1.63 0.32
MHC 33.93 13.68 0.81 0.33
TSS+/–1kb M 56.50 16.43 1.14 0.33
MH 53.89 17.47 0.99 0.32
MHC 30.47 20.18 0.47 0.31
SynoR PWM ECRs (human–mouse) 3.2 13.81 0.07 0.32
Cluster
2 motifs within 100 bp ECMFinder Regex TSS+/–2kb M 15.38 17.98 0.28 0.33
MH 10.77 19.2 0.17 0.30
MHC 4.41 23.38 0.07 0.35
TSS+/–1kb M 14.48 23.3 0.19 0.30
MH 9.03 24.93 0.13 0.35
MHC 3.39 29.86 0.04 0.31
SynoR PWM ECRs (human–mouse) 0.58 20.12 0.01 0.23
3 motifs within 100bp ECMFinder Regex TSS+/–2kb M 1.99 25.2 0.03 0.37
MH 0.46 28.32 0.01 0.59
MHC 0.08 38.89 0.00 0.28
TSS+/–1kb M 1.92 30.24 0.03 0.40
MH 0.39 32.69 0.01 0.48
MHC 0.07 41.94 0.00 0.32
aM: mouse only, MH: mouse–human, MHC: mouse–human–cow.
bSn: sensitivity.
cSl: selectivity.
dBackground: random set (see ‘Materials and methods’ section).
eRegex: regular expressions.
fAlthough the values on the above table are presented in the four digits of signiﬁcance, it is important to note that only the ﬁrst two digits are
statistically important.
The values in bold are signiﬁcantly greater than those by the currently available methods (in gray).
2004 Nucleic Acids Research, 2009, Vol. 37,No. 6database shrank. For example, the CGAT database con-
taining homologous genes from two species (human and
mouse) has 15567 genes, whereas the database with
homologous genes from three species (human, mouse
and cow) has only 7697 genes.
Data setconstruction forvalidation: E2F1 andCTCF
To determine the speciﬁcity of ECMs identiﬁed by
ECMFinder and other methods, we used mouse E2F1
and CTCF ChIP-seq data sets from the literature
(16,17). The ﬂanking regions of the E2F1 and CTCF
ChIP-seq tags, 500bp and 400bp in size, respectively,
were deﬁned as the true binding regions for these proteins
based on the average sizes of ChIP–DNA fragments
described (16,17). In the case of the human CTCF ChIP-
seq data set, we have selected only the regions bound by at
least ﬁve tags. In total 17629 E2F1 and 36835 CTCF-
binding sites were deﬁned as true binding sites for these
proteins in the mouse, while 39442 CTCF-binding sites
were deﬁned as the true binding sites for this protein in
the human. All raw data sets used for validation of the
ECMFinder can be downloaded at: http://jookimlab.
lsu.edu/?q=node/73.
Comparison of ECMFinder withother methods
The performance of ECMFinder was evaluated by com-
paring the predicted versus conﬁrmed DNA-binding sites
of the transcription factor (TF) E2F1. We used the avail-
able E2F1 ChIP-seq data set as a conﬁrmed data set (16).
The performance of ECMFinder was compared with that
of two other programs, SynoR and the HMR conserved
TFBSs (UCSC track). Both methods predict DNA-bind-
ing sites based on the position weight matrix (PWM) pro-
ﬁles of E2F1. SynoR only searches predeﬁned regions
called evolutionary conserved regions (ECRs) for clusters
of DNA-binding sites (more than two motifs). The HMR
conserved TFBSs contains a set of TF-binding sites that
are conserved across the human–mouse–rat alignment
above a certain threshold (default 2.33) for a given binding
matrix (Transfac Matrix Database, v7.0). The following
matrices were used in the HMR conserved TFBSs for the
prediction of the E2F1 motif (PWMs: V$E2F_01,
V$E2F_02 and V$E2F_03). SynoR prediction of clusters
of E2F1-binding sites was performed using the following
matrices (PWMs: E2F1_Q3, E2F1_Q4 and E2F1_Q6).
Single and clustered E2F1-binding sites were also pre-
dicted with ECMFinder. The matrix patterns and regu-
lar expression used in this study are provided in
Supplementary Table 6. The set of predicted binding
sites obtained from each of the above three methods was
compared with the true binding site set derived from the
ChIP-seq data sets. We calculated two values, sensitivity
and selectivity, through comparing the predicted versus
conﬁrmed data sets of E2F1 sites. The sensitivity of each
method was derived from the ratio of total number of
correctly predicted binding sites from a given method to
the total number of the true binding sites. The selectivity
of each method was calculated by dividing the total
number of correctly predicted binding sites by the total
number of predicted binding sites for a given method.
Finally, the sensitivity and selectivity of the three predic-
tions were compared to each other.
ChIP assay
Replicates of ChIP assays were performed more than three
times according to the protocol provided by Upstate
Biotechnology (Upstate Biotech) with minimal modiﬁca-
tions as described previously (14). Brieﬂy, we used mouse
liver tissues from F1 hybrid mice (Mus musculus Mus
spretus) homogenized in 10ml of PBS. Formaldehyde
was added to the samples to a ﬁnal concentration of 1%
and the samples were incubated at 378C for 10min. The
treated samples were sonicated to fractionate the DNA
and immunoprecipitated with anti-YY1 polyclonal anti-
body (catalog no. sc-1703, Santa Cruz Biotechnology) or
anti-CTCF polyclonal antibody (catalog no. 07-729,
Millipore Corporation). The precipitated DNA and
protein complexes were reverse cross-linked and puriﬁed
through phenol/chloroform extraction. Puriﬁed DNA was
used as templates for PCR ampliﬁcation. The primer
sequences used for this study are provided in
Supplementary Table 2. PCR ampliﬁcations were carried
out for 37 cycles using standard PCR conditions. The
ampliﬁed PCR products were analyzed through electro-
phoresis on 2% agarose gels containing ethidium bromide.
DNA methylation analysis through the bisulphite
sequencing method
Bisulﬁte modiﬁcation of genomic DNA derived from
F1 hybrid tissues (M. musculus M. spretus) were
Table 2. Genome-wide CTCF ECMs identiﬁed by ECMFinder
ChIP-seq data (total number) Species comparison ECMFinder (%) Background (%)
a
Sensitivity Selectivity Sensitivity Selectivity
Human (39442) Human only 1.90
b 28.84 0.32 4.89
Human and mouse 0.68 38.1 0.10 5.50
Human–mouse–cow 0.42 36.91 0.06 5.23
Mouse (36835) Mouse only 0.36 22.84 0.09 5.95
Mouse and human 0.21 30.89 0.04 5.24
Mouse–human–cow 0.13 33.8 0.02 6.27
aBackground was calculated using random sets resulting from 10 iterations.
bThe values on the above table are presented in the four digits of signiﬁcance, but only the ﬁrst two digits are statistically important.
The values in bold are greater than those from the background.
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TM kit (Zymo
Research). The bisulﬁte-modiﬁed DNA was ampliﬁed by
a set of primers (Supplementary Table 2). PCR ampliﬁca-
tions were carried out for 38 cycles using standard PCR
conditions (annealing temperature was 588C). The ampli-
ﬁed PCR products were separated by agarose gel electro-
phoresis, and puriﬁed using the MEGA-spin
TM Agarose
Gel Extraction Kit (Intron). Puriﬁed DNA was cloned
into the pGEM T-Easy Vector (Promega), plasmid
DNAs were isolated using the DNA-spin
TM Plasmid
DNA Puriﬁcation Kit (Intron) and ﬁnally sequenced
using BigDye v3.1 (Applied Biosystems).
RESULTS
ECMFinder algorithm and requirements
ECMFinder incorporates the following principles into its
algorithm. First, the motif search of ECMFinder is based
on a text pattern-matching method within the Perl pro-
gramming language. Although PWM approaches provide
more quantitative information about the motif search, they
are not suitable for many TFs that do not have reliable
PWM proﬁles. This has been one of motivations for the
use of text pattern-matching strategies in ECMFinder.
Second, the homologous regions used in ECMFinder
have been deﬁned as the regions surrounding the TSSs of
homologous genes in the HomoloGene database. This
database contains a list of homologous gene groups
that have been derived using protein alignments of
multiplespecies.Indetail,ECMFinderﬁrstscansonegeno-
mic region surroundingthe TSSof agivengene withauser-
deﬁnedmotif.Ifatleastonemotifisidentiﬁedintheregion,
ECMFinder further searches homologous regions from the
otherspeciesusingtheHomoloGenedatabase(Figure1).If
all species have at least one motif in a given homologous
region, this motif is regarded as an ECM.
As a stand-alone program, the genome sequences must
be downloaded and extracted as a chromosomal ﬁle format
within a user’s computer that contains the ECMFinder
program (see ‘Materials and methods’ section) (Step 1 in
Figure 1). To facilitate cross-species indexing of homolo-
gous regions, diﬀerent table database sets from multiple
species and the HomoloGene database were converted
into a single common database, termed ‘CGAT’ (Step 1
in Figure 1). The merged CGAT database contains all the
genes with their position information in multiple species.
The current version of ECMFinder contains CGAT ﬁles
embedded within its compiled program which have been
generated through merging annotation tables for four dif-
ferentspecies: human,mouse,cowandchicken.Itisimpor-
tant to use the same versions of genome sequences. The
genome builds that are compatible with the embedded
CGAT in the current version of ECMFinder are as follows:
human (hg18), mouse (mm9), cow (bosTau4) and chicken
(galGal3) genome sequences.
Performance test of ECMFinder
The performance of ECMFinder was compared with two
genome-wide motif scan methods, SynoR and the HMR
Figure 1. Overall scheme of ECMFinder. ECMFinder uses the CGAT (Common Gene Annotation Table) database, which is the product of merging
homologous gene annotations derived from HomoloGene (release 62) and the genome sequence of four species—human (hg18), mouse (mm9), cow
(bosTau4) and chicken (galGal3). Users can deﬁne an input motif based on the ECMFinder syntax, which is brieﬂy described in the Readme ﬁle of
the program (Step 1). ECMFinder searches a user-deﬁned homologous region (dark blue bar) around a gene’s TSS for the motif (or motif cluster) in
all species. If at least one motif (or motif cluster) exists in the homologous region of all species, they are identiﬁed as ECMs (Evolutionary Conserved
Motifs, red oval) (Step 2). The output of ECMFinder is a GFF (General Feature Format) ﬁle that can be uploaded to the UCSC genome browser as
a Custom Track and visualized along with other data sets (Step 3).
2006 Nucleic Acids Research, 2009, Vol. 37,No. 6conserved TFBS method (Table 1, gray column). For this
comparison, we used E2F1 ChIP-seq data as a set of true
E2F1-binding sites (16). We compared this set of binding
sites with several sets of E2F1-binding sites that were pre-
dicted with the above three methods (see ‘Materials and
methods’ section). We estimated two indexes, sensitivity
and selectivity, for the comparison of the three prediction
methods. The sensitivity index is the ratio of the total
number of binding sites correctly predicted by a given
method to the total number of true binding sites. The
selectivity index is the ratio of the total number of cor-
rectly predicted binding sites to the total number of bind-
ing sites predicted by a given method. This comparison
analysis revealed the following conclusions. First, each
of the three methods achieved much higher levels of sen-
sitivity and selectivity than those from a background set
that had been randomly selected from genomes. Second,
for the prediction of single motifs (the ﬁrst section in
Table 1), ECMFinder outperformed the HMR conserved
TFBS method (the ﬁrst section in Table 1, bold). The sen-
sitivity of ECMFinder ranged from 30.47% to 61.37%
(5371 to 10819/17629), whereas the sensitivity of the
HMR conserved TFBSs was 2.13% (376/17629).
However, the selectivity of the two methods was within
a similar range (11–20% for ECMFinder versus 12.91%
for the HMR conserved TFBSs). Third, for the prediction
of clustered motifs (two or three motifs within a 100-bp
region), the sensitivity index of ECMFinder had overall
higher values than SynoR (the second and third section in
Table 1, bold) although the selectivity by the two methods
was in a similar range (10–40%).
The above comparison also provided the following
insights regarding the strengths of ECMFinder along
with those of the two other methods. ECMFinder per-
formed much better than the two other methods in
terms of sensitivity although all three methods were sim-
ilar in terms of selectivity. ECMFinder’s superior perfor-
mance may be due to the fact that ECMFinder mainly
scanned the region surrounding TSSs. Although the true
binding sites of E2F1 for this analysis were derived from a
single set of ChIP experiments, the observed sensitivity
(30–60%) by ECMFinder suggests that many in vivo bind-
ing sites for this TF are indeed localized in the regions
adjacent to TSSs. Also, the two other prediction methods,
the HMR conserved TFBSs and SynoR, appear to be
unnecessarily stringent in predicting TF-binding sites
without any dramatic increase in selectivity. Also, the lim-
ited number of regions searchable by SynoR may have
missed many true in vivo binding sites for E2F1. Overall,
ECMFinder performed much better than the two other
methods in several categories, in particular the prediction
of single and groups of two E2F1 motifs (within a 100-bp
region) in the regions adjacent to TSSs.
Demonstration I:clustered YY1-binding sites
To demonstrate the feasibility of ECMFinder, we per-
formed two series of motif searches. We chose to identify
binding sites for two well-known TFs, YY1 and CTCF, in
the genomes of three mammals: human, mouse and cow.
The sequence and genome-wide location of the binding
motifs of these two TFs have been well characterized
through large-scale ChIP-chip or ChIP-seq experiments
(13,17,18). YY1-binding sites tend to be located close to
the promoter regions of mammalian genes whereas
CTCF-binding sites are located in both intergenic and
promoter regions. According to recent studies from geno-
mic imprinted domains, clusters of binding sites for these
two TFs coincide with the location of ICRs, but these
ICRs show no sequence conservation among diﬀerent spe-
cies (15). These ICRs may represent a new type of regula-
tory region, and characterization of these regions is one of
the motivations for the current study.
We have used the following criteria to perform a
genome-wide search of clustered YY1-binding sites: the
input motif for YY1-binding sites was ‘cgCCATntt’ with
one allowable mismatch within the bases indicated in low-
ercase; one cluster was deﬁned as the presence of three
YY1 motifs in a 500-bp window; the search was per-
formed within the genomic region spanning 5-kb upstream
and downstream of each gene’s TSS; and three species
(human, mouse and cow) were used to test evolutionary
conservation. With these criteria, ECMFinder identiﬁed
a total of 31 candidate genes that have at least one
ECM in all three species (Supplementary Table 1). These
ECMs were uploaded to the UCSC Genome Browser as
a Custom Track, and the Paternally Expressed Gene 3
(Peg3) locus is shown as a representative locus in
Figure 2A (http://genome.ucsc.edu/cgi-bin/hgTracks?db
=mm9&hgt.customText=http://jookimlab.lsu.edu/sites/
default/ﬁles/yy1_data.txt). The 1st intron of mouse Peg3 is
known to contain at least 10 YY1-binding sites (14), which
were indeed successfully detected by ECMFinder. The
thick black bars represent the YY1 ECMs identiﬁed
within the Peg3’s 1st intron (Figure 2A). Similar YY1
ECMs are also found within the 1st introns of human
and cow PEG3. Yet, the 1st intron of mammalian Peg3
shows almost no sequence conservation as seen in the
graphs derived from PhastCons analysis. This lack of
sequence conservation reﬂects the fact that although
each individual YY1 motif is conserved they diﬀer in
number and spacing between diﬀerent mammals.
Besides the Peg3 locus, ECMFinder identiﬁed 30 addi-
tionallocicontainingclusteredYY1-bindingsites.Detailed
analyses indicated that over half of these clustered
YY1-binding sites are derived from genomic regions that
lack any sequence conservation, but that they all have clus-
ters of YY1-binding sites in homologous regions of the
three species, as seen in the Peg3 locus. We randomly
selected seven out of the 30 predicted loci and performed
ChIPassaystoconﬁrminvivobindingoftheseECMstothe
YY1 protein (Figure 2B). Mouse liver tissues were homo-
genized, treated with formaldehyde to cross-link and
immunoprecipitated with anti-YY1 polyclonal antibodies.
The precipitated DNA was ampliﬁed by PCR with primer
sets targeting the seven chosen loci (primer sequences are
available as Supplementary Table 2). Two loci, Peg3 and
Nr3c1 (nuclear receptor subfamily 3, group C, member 1),
wereincludedaspositivecontrolswhileoneYY1-unrelated
imprinted locus (H19-ICR) and two randomly selected
regions (promoter region of Rcor3, and exon region of
Ppil2)wereincluded asnegativecontrols(14).Asexpected,
Nucleic Acids Research,2009, Vol.37, No. 6 2007six loci (Akt1s1, Fiz1, Prkcsh, Psmb5, Rsrc2 and Sfrs10)
showed high levels of enrichment by the YY1 antibody
(Figure 2B), indicating that these regions are bound by
YY1 in vivo. However, we could not conﬁrm the in vivo
bindingofYY1 totheremaining locus(Sox4).Werepeated
analysis of this locus using two other tissues, brain and
testis, but we could not detect any enrichment by the
YY1-ChIP (Figure 2B). Thus, we concluded that this
locus is either a false positive or a very developmental
stage-speciﬁc binding site. In sum, ECMFinder identiﬁed
31 clustered YY1-binding sites that are conserved among
mammals, and we show that most of the clustered sites are
bona ﬁde in vivo YY1-binding sites.
Demonstration II: clustered CTCF-binding sites
In contrast to YY1, a large fraction of CTCF-binding sites
are known to be located in intergenic regions that are
characterized by low levels of sequence conservation
(13). Since existing programs target mainly ECRs, which
tend to be located close to or within genes, we predict
that these programs may miss many functionally
relevant CTCF-binding sites, but that our new approach
using ECMFinder may be more suitable for identifying
this type of TFBS. Thus, we performed another series of
motif searches with ECMFinder aiming to locate genome-
wide clustered CTCF-binding sites.
We used the following criteria for this search: the input
motif for CTCF was either ‘CCGCnnGGnGGCAG’
with one allowable mismatch or ‘CCGCnnGGnGG’
with no mismatches allowed; a cluster was deﬁned as
three CTCF-binding sites within a 5-kb window; the
search area encompasses the –150 to+150-kb region sur-
rounding each gene’s TSS; one to three species (human,
mouse and cow) were used to test evolutionary
Figure 2. Visualization and in vivo conﬁrmation of the clustered YY1-binding sites predicted by ECMFinder. (A) Clusters of YY1-binding sites
located within the 1st intron of Peg3 were visualized along with other data using the Custom Track. Each cluster of conserved YY1-binding sites
detected by ECMFinder is indicated by a thick black line in the top track. The following tracks are provided from the UCSC genome browser
(RefSeq for gene annotations, PhastCons for conservation, RepeatMasker for repeat elements, HMR conserved Transcription Factor Binding Sites
for predicted TFBSs). In the human box, the HMR (human, mouse and rat) conserved TFBSs method using PWM matrix failed to predict the
presence of the YY1-binding sites due to the low conservation level of this region. However, all three species have clustered YY1-binding sites within
the 1st intron of Peg3. (B) YY1–ChIP results of candidate genes. This series of YY1–ChIP analysis were performed to conﬁrm the in vivo binding of
YY1 to each locus predicted by ECMFinder. The ampliﬁed PCR products from each locus are shown in the following order: the Input (lane 1), the
IgG lane with rabbit normal serum (lane 2) and the YY1 Ab lane with YY1 antibody (lane 3). The two previously known YY1-binding sites were
used as positive controls (Nr3c1 and Peg3, blue), whereas three YY1-unrelated loci were used as negative controls (H19-ICR, the promoter region of
Rcor3, and the exon region of Ppil2, red). We tested seven randomly chosen loci out of the 31 predicted YY1 clustered regions, including Akt1s1,
Fiz1, Prkcsh, Psmb5, Rsrc2, Sfrs10 and Sox4.
2008 Nucleic Acids Research, 2009, Vol. 37,No. 6conservation. With these criteria, ECMFinder identiﬁed a
total of 2604, 706 and 447 CTCF-binding sites in
the human and a total of 578, 246 and 142 CTCF-binding
sites in the mouse with the conservation test using one spe-
cies (human or mouse), two species (human–mouse)
and three species (human–mouse–cow comparison),
respectively. The sensitivity and selectivity by the
ECMFinder prediction were above those of the back-
ground set in all of the three categories (Table 2, bold).
However, the sensitivities of all three categories were
very low (below 2%) due to the high level of stringency
used for this prediction. On the other hand, much
higher levels of selectivity, ranging from 28.84 to
38.10%, were achieved when we compared the predicted
set with the CTCF ChIP-seq data sets (Table 2). The
CTCF ECMs identiﬁed through comparison between
two species (human–mouse) were further selected and
uploaded to UCSC Custom Track along with the results




Initial inspection of the above uploaded CTCF sites
resulted in the following conclusions. First, 38.10%
(269/706) of the human and 30.89% (76/246) of the
mouse CTCF ECMs identiﬁed by ECMFinder are
indeed in vivo CTCF-binding sites based on the available
ChIP-seq data. To test if the rest of the CTCF ECMs are
false positives, we performed individual ChIP experiments
on a set of seven randomly selected false-positive loci.
Surprisingly, four out of these seven sites were conﬁrmed
to be true binding sites. This sample test further indicates
that the selectivity (30.89% in the mouse) of the
ECMFinder prediction is most likely underestimated.
We believe that the actual selectivity value should be
higher based on our independent estimate of an actual
false-positive fraction in the predicted CTCF ECM set,
43% (three out of seven loci) (Supplementary Table 4).
Second,  51% of the identiﬁed CTCF ECMs in human
are indeed localized in the intergenic or intron regions of
each gene, which are not conserved among mammalian
species (Supplementary Table 3) (20). Third, a number
of well-known imprinted loci appear to be associated
with clustered CTCF-binding sites: IGF2/H19 domain
Figure 3. Distribution of the identiﬁed CTCF ECMs in the human genome. The density of the CTCF ECMs is represented on the UCSC genome
graph. All ECMs shown here were conﬁrmed using previously published genome-wide CTCF ChIP-seq data (17) and exact position of each ECM is
available as Supplementary Table 3. The blue peak indicates the density of CTCF ECMs identiﬁed by ECMFinder. We identiﬁed 174 loci with
clustered CTCF-binding sites that are conserved between two species (human and mouse). The two imprinted loci with the clustered CTCF-binding
sites are indicated by red squares, IGF2/H19 in the chromosome 11 and DLK1-DIO3 in the chromosome 14. Detailed inspection of the
clustered CTCF sites identiﬁed by ECMFinder is available by browsing the UCSC Custom Track (http://genome.ucsc.edu/cgi-bin/
hgTracks?db=hg18&hgt.customText=http://jookimlab.lsu.edu/sites/default/ﬁles/ctcf_data.txt).
Nucleic Acids Research,2009, Vol.37, No. 6 2009and DLK1-DIO3 domain. As expected, ECMFinder suc-
cessfully identiﬁed previously known CTCF-binding
sites—H19-ICR in the IGF2/H19 domain and
MEG3-DMR in the DLK1-DIO3 domain (Figure 3). We
have also identiﬁed a new conserved cluster of CTCF-
binding sites in the region  75kb upstream of DLK1,
and several single CTCF-binding sites that are located
close to the following imprinted genes: MAGEL2,
CDKN1C and GNAS. We have conﬁrmed the in vivo bind-
ing of CTCF to DLK1, MAGEL2 and CDKN1C through
individual ChIP (Supplementary Table 5).
Among the clustered CTCF-binding sites identiﬁed by
ECMFinder, we further analyzed one clustered CTCF-
binding site that was identiﬁed from the DLK1-DIO3
domain in human chromosome 14 (Figures 3 and 4).
This particular CTCF ECM, called DLK1-BE
(Boundary Element), was highly conserved in terms of
cluster size ( 4kb), number of motifs (3–4), and relative
position (69–75kb upstream from the DLK1’s TSS)
among the three species tested (Figure 4A). In addition,
genome-wide ChIP-seq and ChIP-chip data also con-
ﬁrmed in vivo binding of CTCF to the human region of
this clustered CTCF sites (ﬁrst and second tracks in
Figure 4A). The lack of obvious spikes in the PhastCons
mammal conservation graph shows that overall sequence
conservation of this cluster of CTCF-binding sites is very
low (bottom of Figure 4A). Consistently, sequence align-
ments of the regions surrounding three CTCF-binding
sites also indicate no obvious cross-species conservation
beyond the CTCF-binding sites (sequence alignment
Figure 4. CTCF ECMs in the DLK1-DIO3 domain. (A) Custom Track View of human chromosome 14. The ﬁrst track shows the density of genome-
wide CTCF ChIP-seq data (17). The second track shows the log2 value of genome-wide CTCF ChIP-chip data (13). The third and fourth tracks
indicate the CTCF ECMs and CTCF single binding motif detected by ECMFinder, respectively. The remaining tracks have been derived from the
UCSC genome browser. The CTCF motifs are conserved although their ﬂanking sequences have degenerated. Each sequence includes a CTCF motif
(red) with its immediate surrounding regions (bottom left). The middle section shows the Dlk1-Dio3 domain in mouse chromosome 12. Maternally
and paternally expressed genes are indicated by red and blue arrows, respectively. Sequence alignments of individual CTCF-binding sites and their
ﬂanking regions are also shown in the bottom left section. (B) ChIP conﬁrmation of the three CTCF sites using mouse liver tissues. The Gtl2-DMR
and H19-ICR were used as positive controls, and the Dlk1-30 DMR was used as a negative control. Individual ChIP results from the three CTCF
sites are shown below with their site numbers. (C) The ﬁrst CTCF-binding site (#1) is well conserved among seven mammalian species (mouse, rat,
human, orangutan, dog, horse and opossum). (D) PvuII enzyme digestion of CTCF ChIP–PCR product with an input control. PvuII digests only the
paternal DNA (Mus spretus). The upper band is an undigested DNA (300bp) and the lower band is a 241-bp fragment of DNA digested by PvuII.
(E) Results of bisulﬁte sequencing of the 957-bp region surrounding the CTCF site #1. The closed and open circles indicate methylated and
unmethylated CpGs, respectively. The red triangle represents the position of the CTCF site #1. The bisulﬁte sequencing results were further separated
based on parental origin indicated by sex symbols and species names.
2010 Nucleic Acids Research, 2009, Vol. 37,No. 6in Figure 4A). The human region of this cluster of CTCF-
binding sites has an additional CTCF site in the 50-side,
named CTCF site #0. Interestingly, one particular CTCF
site (CTCF site #1 in Figure 4C) displays unusually high
levels of sequence conservation up to the marsupial lin-
eage with only one base diﬀerence (A->C) in the following
three species: mouse, rat and opossum.
To further characterize this clustered CTCF site, we
performed another ChIP experiment using mouse liver
tissues derived from hybrid mice obtained from the inter-
speciﬁc crossing of M. musculus and M. spretus. This
hybrid system has been previously used to test allele-
speciﬁc binding of YY1 to several imprinted domains.
ChIP experiments targeting the three CTCF sites indeed
conﬁrmed in vivo binding of CTCF to sites #1 and #2, but
not to site #3 (Figure 4B). We included two positive con-
trols (Gtl2-DMR and H19-ICR) as well as one negative
control (Dlk1-30DMR) for this analysis. The enrichment
levels at site #1 were much higher than those of site #2. We
also tested whether the CTCF binding to the site #1 is
allele speciﬁc by digesting the immunoprecipitated DNA
with the restriction enzyme PvuII. In this scheme, only the
paternal allele is digested by the PvuII enzyme due to the
presence of a sequence polymorphism between two paren-
tal species. According to the results of our repeated ChIP
trials, the CTCF binding to these two sites, in particular
#1, is biallelic: in three out of four independent trials the
CTCF antibody precipitated an equal amount of the two
alleles’ DNA (Figure 4D). This suggests that CTCF binds
to both alleles of this CTCF site. Within imprinted
domains, CTCF is known to bind to CpG islands in an
allele-speciﬁc manner, and DNA methylation usually
blocks the binding of CTCF to its target sites (20,21).
Therefore, we also tested the DNA methylation status of
the 1-kb region surrounding CTCF site #1 (Figure 4E).
According to the results from bisulﬁte sequencing, neither
allele is methylated in this region, indicating that this
region is not a diﬀerentially methylated region (DMR).
This result is consistent with the initial observation that
CTCF binds to both alleles of this region. Since this
CTCF site is located outside of the Dlk1-Dio3 domain,
and well conserved among all the species of mammals,
we predict that this CTCF site may be a boundary element
demarcating this imprinted domain. In conclusion,
ECMFinder identiﬁed many clustered CTCF sites,
and approximately half of these predicted sites are likely
genuine in vivo binding sites for CTCF.
DISCUSSION
The current study presented a new bioinformatics tool
(ECMFinder) that can be used to identify functionally
relevant TFBSs. This approach is based on the assump-
tion that any functionally relevant TFBS may have some
Figure 4. Continued.
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distance to nearby associated genes. To test this idea,
ECMFinder has utilized gene association information to
test the evolutionary conservation of potential TFBS.
With this program, we successfully identiﬁed many
YY1- and CTCF-binding sites, most of which were
found to be genuine in vivo binding sites. The two demon-
strations presented in this study suggest that ECMFinder
will be a useful resource for studying regulatory biology in
the near future.
ECMFinder has the following advantages compared to
existing approaches. First, ECMFinder performs unrest-
ricted searches for potential TFBSs. At the same time,
ECMFinder utilizes gene association and evolutionary
conservation information to ﬁlter out the vast majority
of false-positive results. These two ideas have proven to
be eﬀective in identifying many functionally relevant
TFBSs based on the results of YY1- and CTCF-binding
site studies (Figures 2 and 3). As expected, a large fraction
of the identiﬁed YY1 and CTCF sites are also found in
nonconserved and/or intergenic regions of mammalian
genomes, which are usually ignored by existing programs.
Yet, many of these sites are actual in vivo binding sites for
both proteins. Second, since ECMFinder uses gene asso-
ciation information, an identiﬁed TFBS is tied to its
nearby gene(s). This feature of ECMFinder is very
useful for merging its genome-wide TFBS prediction
data sets with other existing genomic data, such as micro-
array-based expression, ChIP-chip and ChIP-seq data.
For instance, as shown in Figure 4, the existing genome-
wide ChIP-chip and ChIP-seq data of CTCF can be read-
ily compared with the CTCF-binding site prediction
results derived from ECMFinder. This will eventually
allow a user to decide quickly if a potential TFBS is a
genuine in vivo binding site. This has been one of motiva-
tions for using the Custom Track-compatible GFF format
as the default output of ECMFinder.
Based on results from these two examples, ECMFinder
also has the following problems that need to be improved
in the future. First, ECMFinder uses gene association
information as a main ﬁltering tool. Thus, if one of the
genome sequences used for ECMFinder is not well anno-
tated, this could easily ﬁlter out many functionally rele-
vant TFBSs from its original prediction set. Among the
species we used for the current version (human, mouse and
cow), the annotation of the cow genome sequence may not
be as accurate and complete as the two others based on the
number of annotated genes in the database (17861, 17782
and 8587 genes in human, mouse and cow, respectively).
As such, we estimate that the real numbers of clusters of
YY1- and CTCF-binding sites may be greater than the
actual numbers presented in this study. Second,
ECMFinder’s search method is based on pattern matching
rather than PWMs. Thus, TFBS search by ECMFinder is
probably more rigid and stringent than other existing pro-
grams. On the other hand, only  15% TFs have reliable
PWM proﬁles. Therefore, using ECMFinder with a pat-
tern-matching approach may be a necessary compromise
at the current stage of regulatory biology. Also, more
annotated genome sequences, which are on the horizon,
will add more ﬁltering power to the evolutionary
conservation test used in ECMFinder. In that situation,
ECMFinder could lower the stringency of the pattern-
matching criteria by allowing more leniency in its input
motifs.
One of the identiﬁed CTCF sites displays unusual high
levels of sequence conservation among diﬀerent mammals,
even in marsupials (CTCF site #1 in DLK1-BE,
Figure 4C). This conservation predicts that this single
CTCF-binding site should play a signiﬁcant role for the
nearby genes in the DLK1-DIO3 imprinted domain. Since
CTCF is known to act as an enhancer-blocker (22,23), this
CTCF-binding site might be a boundary for demarcating
this imprinted domain from its neighboring regions.
However, it is important to note that this CTCF site is
also found in marsupials, where the DLK1-DIO3 domain
is not imprinted (24). Thus, the enhancer-blocker activity
associated with this CTCF site may not play a direct role
in determining or maintaining the genomic imprinting of
this domain. Nevertheless, it will be interesting to test this
possibility in the future. Since we have already been work-
ing on imprinted domains at the beginning of this study,
the identiﬁcation of this particular CTCF site should not
be regarded as an automatic discovery using ECMFinder,
but as a serendipitous discovery involving manual inspec-
tions. Regardless, this represents the ideal situation where
a single conserved TFBS could be identiﬁed with high
levels of conﬁdence and biological signiﬁcance. Although
similar analyses are not immediately possible with the cur-
rent stage of bioinformatics, more available genome
sequences will eventually help investigators identify simi-
lar TFBSs as demonstrated in this particular CTCF site
(Figure 4C).
In summary, ECMFinder appears to provide several
advantages to users. First, users can search any motif of
interest on a genome-wide scale with improved sensitivity
and selectivity over existing methods. Second, the results
from ECMFinder can be visualized and analyzed along-
side other data in the UCSC genome browser.
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